Cerebrospinal fluid 14-3-3-gamma protein level in eight HIV-negative cryptococcal meningitis adults

W N Chang1, C H Lu, C R Huang

  • 1Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan. cwenneng@ms19.hinet.net

Insights

Elevated cerebrospinal fluid (CSF) 14-3-3-gamma protein is found in HIV-negative patients with cryptococcal meningitis (CM). This protein level did not change with short-term treatment in this study.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Biochemistry

Background:

  • Cryptococcal meningitis (CM) is a serious fungal infection affecting the central nervous system.
  • Diagnosis and prognosis in HIV-negative CM patients can be challenging.
  • Cerebrospinal fluid (CSF) biomarkers are crucial for understanding CM pathogenesis and outcomes.

Purpose of the Study:

  • To investigate the levels of CSF 14-3-3-gamma protein in adult HIV-negative patients with CM.
  • To assess the correlation of CSF 14-3-3-gamma protein levels with clinical parameters and treatment outcomes.
  • To determine if CSF 14-3-3-gamma protein levels change with short-term treatment.

Main Methods:

  • Retrospective analysis of clinical data from eight adult HIV-negative CM cases.
  • Detection and quantification of 14-3-3-gamma protein in cerebrospinal fluid (CSF) using specific assays.
  • Correlation analysis between CSF 14-3-3-gamma protein levels, CSF white blood cell counts, and therapeutic results.

Main Results:

  • All eight HIV-negative CM patients exhibited positive CSF 14-3-3-gamma protein detection at initial and follow-up studies.
  • Elevated CSF 14-3-3-gamma protein levels were observed in this cohort.
  • No significant correlation was found between CSF 14-3-3-gamma protein densitometric values and CSF white blood cell counts or therapeutic outcomes.
  • Mortality rate was 37.5% (3/8), and 60% (3/5) of survivors experienced significant neurological deficits.
  • CSF 14-3-3-gamma protein levels remained unchanged with short-term treatment.

Conclusions:

  • HIV-negative CM patients demonstrate elevated CSF 14-3-3-gamma protein.
  • CSF 14-3-3-gamma protein levels do not appear to correlate with disease severity markers or treatment response in the short term.
  • Further research is warranted to explore the diagnostic and prognostic value of CSF 14-3-3-gamma protein in cryptococcal meningitis.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cerebrospinal Fluid01:21

Cerebrospinal Fluid

Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain.
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...